BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7296513)

  • 1. Multiple histologic subtypes of non-Hodgkin's lymphoma: clinical and pathologic features.
    Leyser S; Variakojis D; Mintz U; Vardiman JW; Ultmann JE
    Cancer; 1981 Nov; 48(9):2063-9. PubMed ID: 7296513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
    Conlan MG; Bast M; Armitage JO; Weisenburger DD
    J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease.
    Kant JA; Hubbard SM; Longo DL; Simon RM; DeVita VT; Jaffe ES
    J Clin Oncol; 1986 Mar; 4(3):284-94. PubMed ID: 3754003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic transformation in extranodal non-Hodgkin's lymphoma.
    Aozasa K; Ikeda H; Masaki N; Shigematsu Y
    Acta Pathol Jpn; 1984 Jul; 34(4):767-74. PubMed ID: 6485795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
    Gonzalez CL; Medeiros LJ; Jaffe ES
    Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-associated extranodal non-Hodgkin's lymphoma of the sinonasal tract and nasopharynx in Thailand.
    Mitarnun W; Suwiwat S; Pradutkanchana J
    Asian Pac J Cancer Prev; 2006; 7(1):91-4. PubMed ID: 16629523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic conversion in the non-Hodgkin's lymphomas.
    Acker B; Hoppe RT; Colby TV; Cox RS; Kaplan HS; Rosenberg SA
    J Clin Oncol; 1983 Jan; 1(1):11-6. PubMed ID: 6366124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical aspects of non-Hodgkin's lymphomas presenting with discordant histologic subtypes.
    Mead GM; Kushlan P; O'Neil M; Burke JS; Rosenberg SA
    Cancer; 1983 Oct; 52(8):1496-501. PubMed ID: 6352001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous malignant lymphoma: a pathologic study of 50 cases with clinical analysis of 37.
    Burke JS; Hoppe RT; Cibull ML; Dorfman RF
    Cancer; 1981 Jan; 47(2):300-10. PubMed ID: 7459818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan.
    Chen WL; Tsai WC; Chao TY; Sheu LF; Chou JM; Kao WY; Chen YC; Ho CL
    Ann Hematol; 2010 Jun; 89(6):553-62. PubMed ID: 20012434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.
    Miller DC; Hochberg FH; Harris NL; Gruber ML; Louis DN; Cohen H
    Cancer; 1994 Aug; 74(4):1383-97. PubMed ID: 8055462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
    Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
    J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extranodal non-Hodgkin's lymphomas--a retrospective review of clinico-pathologic features and outcomes in comparison with nodal non-Hodgkin's lymphomas.
    Lal A; Bhurgri Y; Vaziri I; Rizvi NB; Sadaf A; Sartajuddin S; Islam M; Kumar P; Adil S; Kakepoto GN; Masood N; Khurshed M; Alidina A
    Asian Pac J Cancer Prev; 2008; 9(3):453-8. PubMed ID: 19004134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
    Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
    Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma.
    Juneja SK; Wolf MM; Cooper IA
    J Clin Pathol; 1990 Aug; 43(8):630-2. PubMed ID: 2401730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FNAC of malignant lymphoma in an area with a high incidence of T-cell lymphoma. Correlation of accuracy of cytologic diagnosis with histologic subtype and immunophenotype.
    Park IA; Kim CW
    Acta Cytol; 1999; 43(6):1059-69. PubMed ID: 10578979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated bone marrow non-Hodgkin's lymphoma: a clinicopathologic study.
    Ponzoni M; Li CY
    Mayo Clin Proc; 1994 Jan; 69(1):37-43. PubMed ID: 8271848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of histologic type on survival in early extranodal non-Hodgkin's lymphoma in head and neck.
    Aozasa K; Nara H; Ikeda H; Masaki N; Miyata Y; Matsuzuka F; Shigematsu Y
    Oncology; 1984; 41(3):164-9. PubMed ID: 6728399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eight-year experience of malignant lymphoma--survival and prognostic factors.
    Hahn JS; Lee S; Chong SY; Min YH; Ko YW
    Yonsei Med J; 1997 Oct; 38(5):270-84. PubMed ID: 9409190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.